Iselin, NJ, November 14, 2017--A new compound to coat endotracheal tubes and other medical devicies to prevent bacterial and fungal colonization and growth of biofilms may be an important addition to the armamentarium against hospital-acquired infection and the development of superbugs, according to Carl Genberg, BSc, JD, CEO, at the Superbugs & Superdrugs 2017 conference.
Preclinical testing on this new compound, which is comprised of an innate immune mimic synthetic molecule, has just been completed, and clinical testing is due to begin, he explained.
Genberg also highlighted concerns about colonization with fungi, which is often overlooked, and how this contributes to the toxicity of superbugs, and the incidence of hospital acquired infection. Overuse of antibiotics has allowed for the proliferation of fungal pathogens, such as Candida auris. According to Genberg, the colonization of both fungi and bacteria on medical devices synergize and work to increase the toxicity of hospital-acquired infections.